DongKoo Bio & Pharma Co., Ltd. (006620.KQ) Financial Forecast
South Korea · Industrial & Consumer Products · KRW (Millions) · Annual
Key financials
KRW|Millions
ROE
39.12%
2025 (actual)
ROA
17.32%
2025 (actual)
Gross Margin
59.54%
2025 (actual)
Net Margin
20.71%
2025 (actual)
Total Assets
₩336,349.56M
2025 (actual)
Net Income
₩50,272.42M
2025 (actual)
Valuation
₩147,920.33M
2026 (forecast)
Stock Price
₩5,470
Historical & projected performance
KRW|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-21.6 pt
Company
Sector average
ROA
-6.5 pt
Company
Gross Margin
-1.3 pt
Company
Sector average
Net Margin
-6.6 pt
Company
Total Assets
+80.6%
Company
Sector average (own scale)
Net Income
+23.6%
Company
Sector average (own scale)
Valuation
+22%
Company
Sector average (own scale)
Amounts in KRW (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for DongKoo Bio & Pharma Co., Ltd.? It covers the balance sheet, income statement, cash flow and Equlion model projections.